🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vicki Fellowes

National Institutes of Health

ORCID: 0009-0007-0810-2051

Also affiliated with National Cancer Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Table 1 from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

(2023)10.1158/1078-0432.22443327
Top 100%
0DataRank
Top 100%0 citations

Miriam E. Mossoba, Seth M. Steinberg, Vicki Fellowes, Xiaoyi Yan, Frances T. Hakim +14 more

Papers

Driven by 6 papers — median percentile 0. Top paper: “Group O plasma as a media supplement for CAR‐T cells and other adoptive T‐cell therapies”.

Group O plasma as a media supplement for CAR‐T cells and other adoptive T‐cell therapies

Transfusion(2020)10.1111/trf.15745
N/A
0DataRank · unranked
0 citations

Vicki Fellowes, Ping Jin, Hui Liu, Steven L. Highfill, Jiaqiang Ren +4 more

Supplementary Table 1 from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

(2023)10.1158/1078-0432.22443327
Top 100%
0DataRank
Top 100%0 citations

Miriam E. Mossoba, Seth M. Steinberg, Vicki Fellowes, Xiaoyi Yan, Frances T. Hakim +14 more

Data from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

(2023)10.1158/1078-0432.c.6519780.v1
N/A
0DataRank · unranked
0 citations

Miriam E. Mossoba, Seth M. Steinberg, Vicki Fellowes, Xiaoyi Yan, Frances T. Hakim +14 more

Supplementary Table 1 from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22443327.v1
Top 100%
0DataRank
Top 100%0 citations

Miriam E. Mossoba, Seth M. Steinberg, Vicki Fellowes, Xiaoyi Yan, Frances T. Hakim +14 more

CAR-T cell expansion platforms yield distinct T cell differentiation states

Cytotherapy(2024)10.1016/j.jcyt.2024.03.003
N/A
0DataRank · unranked
45 citations

Michaela Prochazkova, Lipei Shao, Roshini Traynor, Sarah Underwood, Mary A. Black +12 more

Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia

Molecular Therapy — Methods & Clinical Development(2024)10.1016/j.omtm.2024.101212
N/A
0DataRank · unranked
6 citations

Katherine A. Weissler, Vicki Fellowes, Norris Lam, Lauren C. Cutmore, Danielle Natrakul +3 more